The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic Sclerosis

Journal of Investigative Dermatology

Volumn 136, Issue 4, 2016, Pages 762-769

  Kanno, Yosuke ^a   Shu, En ^b   Kanoh, Hiroyuki ^b   Seishima, Mariko ^b  

^a DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTIFIBROTIC AGENT; BLEOMYCIN; COLLAGEN; SMALL INTERFERING RNA;

3T3 CELL LINE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOGRAM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; FIBROBLAST; FIBROSIS; LUNG; METABOLISM; PATHOLOGY; SKIN;

ALPHA-2-ANTIPLASMIN; ANIMALS; BLEOMYCIN; CELL DIFFERENTIATION; COLLAGEN; DISEASE MODELS, ANIMAL; FIBROBLASTS; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MICE; MICE, INBRED C57BL; MYOFIBROBLASTS; RNA, SMALL INTERFERING; SCLERODERMA, SYSTEMIC; SKIN;

EID: 84978115029     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2015.12.028     Document Type: Article

References (23)

1. Ashcroft, T., Simpson, J.M., Timbrell, V., Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41 (1988), 467–470.
2. Bauman, K.A., Wettlaufer, S.H., Okunishi, K., Vannella, K.M., Stoolman, J.S., Huang, S.K., et al. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. J Clin Invest 120 (2010), 1950–1960.
3. Collen, D., Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. Eur J Biochem 69 (1976), 209–216.
4. Eddy, A., Serine proteases, inhibitors and receptors in renal fibrosis. Thromb Haemost 101 (2009), 656–664.
5. Eddy, J.L., Schroeder, J.A., Zimbler, D.L., Bellows, L.E., Lathem, W.W., Impact of the Pla protease substrate α2-antiplasmin on the progression of primary pneumonic plague. Infect Immun 83 (2015), 4837–4847.
6. Gilbane, A.J., Denton, C.P., Holmes, A.M., Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells. Arthritis Res Ther, 15, 2013, 215.
7. Hattori, N., Mizuno, S., Yoshida, Y., Chin, K., Mishima, M., Sisson, T.H., et al. The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism. Am J Pathol 164 (2004), 1091–1098.
8. Hou, Y., Okada, K., Okamoto, C., Ueshima, S., Matsuo, O., Alpha2-antiplasmin is a critical regulator of angiotensin II-mediated vascular remodeling. Arterioscler Thromb Vasc Biol 28 (2008), 1257–1262.
9. Jinnin, M., Ihn, H., Yamane, K., Asano, Y., Yazawa, N., Tamaki, K., Plasma plasmin-alpha2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension. Rheumatology 42 (2003), 240–243.
10. Junqueira, L.C., Bignolas, G., Brentani, R.R., Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11 (1979), 447–455.
11. Kager, L.M., Weehuizen, T.A., Wiersinga, W.J., Roelofs, J.J., Meijers, J.C., Dondorp, A.M., et al. Endogenous α2-antiplasmin is protective during severe gram-negative sepsis (melioidosis). Am J Respir Crit Care Med 188 (2013), 967–975.
12. Kanno, Y., Hirade, K., Ishisaki, A., Nakajima, K., Suga, H., Into, T., et al. Lack of alpha2-antiplasmin improves cutaneous wound healing via over-released vascular endothelial growth factor-induced angiogenesis in wound lesions. J Thromb Haemost 4 (2006), 1602–1610.
13. Kanno, Y., Kaneiwa, A., Minamida, M., Kanno, M., Tomogane, K., Takeuchi, K., et al. The absence of uPAR is associated with the progression of dermal fibrosis. J Invest Dermatol 128 (2008), 2792–2797.
14. Kanno, Y., Kawashita, E., Kokado, A., Kuretake, H., Ikeda, K., Okada, K., et al. α2AP mediated myofibroblast formation and the development of renal fibrosis in unilateral ureteral obstruction. Sci Rep, 4, 2014, 5967.
15. Kanno, Y., Kawashita, E., Kokado, A., Okada, K., Ueshima, S., Matsuo, O., et al. Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F2α synthesis through adipose triglyceride lipase/calcium-independent phospholipase A2. Arthritis Rheum 65 (2013), 492–502.
16. Kanno, Y., Kawashita, E., Minamida, M., Kaneiwa, A., Okada, K., Ueshima, S., et al. Alpha2-antiplasmin is associated with the progression of fibrosis. Am J Pathol 176 (2010), 238–245.
17. Kanno, Y., Kuroki, A., Okada, K., Tomogane, K., Ueshima, S., Matsuo, O., et al. Alpha2-antiplasmin is involved in the production of transforming growth factor beta1 and fibrosis. J Thromb Haemost 5 (2007), 2266–2273.
18. Kawakami, M., Kawagoe, M., Harigai, M., Hara, M., Hirose, T., Hirose, W., et al. Elevated plasma levels of alpha 2-plasmin inhibitor-plasmin complex in patients with rheumatic diseases. Possible role of fibrinolytic mechanism in vasculitis. Arthritis Rheum 32 (1989), 1427–1433.
19. Kochtebane, N., Choqueux, C., Passefort, S., Nataf, P., Messika-Zeitoun, D., Bartagi, A., et al. Plasmin induces apoptosis of aortic valvular myofibroblasts. J Pathol 221 (2010), 37–48.
20. Lijnen, H.R., De Cock, F., Van Hoef, B., Schlott, B., Collen, D., Characterization of the interaction between plasminogen and staphylokinase. Eur J Biochem 224 (1994), 143–149.
21. Okada, K., Ueshima, S., Kawao, N., Yano, M., Tamura, Y., Tanaka, M., et al. Lack of both α2-antiplasmin and plasminogen activator inhibitor type-1 induces high IgE production. Life Sci 93 (2013), 89–95.
22. Varga, J., Pasche, B., Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol 5 (2009), 200–206.
23. Zhabin, S.G., Gorin, V.S., The effects of alpha 2-antiplasmin complex and alpha 2-antiplasmin on the secretion of IgG and IgM by cultured human mononuclear cells. J Clin Lab Immunol 49 (1997), 77–82.